You are here

R&D

Pfizer discards eczema, NASH and breast cancer programs in early-phase clean-out

Fierce Biotech

Tue, 11/1/22 - 12:09 pm

Covid-19 spurred a historic vaccine R&D effort. What does it mean for future pandemics?

Endpoints

Tue, 11/1/22 - 11:06 am

EpiVax partners with Intravacc, CEPI for betacoronavirus vaccine development

Pharmaceutical Business Review

Tue, 11/1/22 - 11:01 am

betacoronaviruses

Autoimmune drug biotech HI-Bio unveils $120M to root out cellular drivers of disease

MedCity News

Tue, 11/1/22 - 10:55 am

Human Immunology Bioscience

autoimmune disease

Sanofi and BioMed X Partner to Predict Efficacy with Virtual Patient Populations

BioSpace

Mon, 10/24/22 - 11:03 pm

artificial intelligence

virtual patients

First-of-its-kind Whole Lung Simulator is Helping Michigan Researchers Predict New Treatments and Vaccines for TB – A Reemerging Global Health Threat

Mon, 10/24/22 - 12:55 pm

Altamira finds buyer for Zilentin inner ear unit so Swiss biotech can go all-in on RNA

Fierce Biotech

Sun, 10/23/22 - 06:54 pm

Altamira Therapeutics

Summit makes case for changes to antibiotic R&D after sharing data from failed phase 3 trial

Fierce Biotech

Fri, 10/21/22 - 10:59 am

Summit Therapeutics

clinical trials

Novartis-partnered Orionis secures $55M to push cytokine program into clinic

Endpoints

Wed, 10/19/22 - 10:55 am

Orionis Biosciences

Months after slimming its R&D focus, Orion realigns stars in top-down organizational restructure

Fierce Biotech

Mon, 10/17/22 - 10:49 am

NovaQuest Private Equity Announces Investment In Bend Bioscience to Broaden CoreRx Offering

CP WIre

Mon, 10/17/22 - 10:41 am

Bend Biosciences

drug manufacturing

NovaQuest Private Equity Announces Investment In Bend Bioscience to Broaden CoreRx Offering

Mon, 10/17/22 - 10:15 am

Bend Biosciences

drug manufacturing

Big Pharma Says Drug Prices Reflect R&D Cos, but new study finds no correlation between research and development spending and outlandish drug prices

Wired

Fri, 10/14/22 - 10:18 am

Eisai cuts the ribbon on $69M injectable drug delivery facility

Fierce Pharma

Tue, 10/11/22 - 10:26 am

R&D acceleration: Amgen opens its second largest research site, with lab and office space for 650 staff

Endpoints

Fri, 10/7/22 - 11:02 am

Boehringer and Surrozen Seek Retinal Therapies Along the Wnt Pathway

BioSpace

Fri, 10/7/22 - 10:39 am

Boehringer Ingelheim

retinal diseases

Why Vertex Pharmaceuticals' Shares Rose 2.8% in September

Motley Fool

Wed, 10/5/22 - 10:33 am

Vertex Pharmaceuticals

cystic fibrosis

White House’s open-access research directive scrambles long-entrenched models, raising key questions

Stat

Mon, 10/3/22 - 09:59 am

federal funding

European pharma group wants to create PRV-like system to spur antibiotics R&D

Endpoints

Sun, 10/2/22 - 07:51 pm

priority review vouchers

Ordaōs/NonExomics Deal Shines Light on Novel Mini-Proteins

BioSpace

Thu, 09/29/22 - 10:14 am

Pages